Utama › Aterosklerosis › North Carolina
Kajian klinikal Aterosklerosis di North Carolina
12 kajian untuk Aterosklerosis sedang mencari peserta di lokasi di North Carolina.
Bandar di North Carolina
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- UNC Heart & Vascular, Chapel Hill
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Care Access - Fayetteville, Fayetteville
- Medication Management, Greensboro
- Monroe Biomedical Research, Monroe
- dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07157774Study of the Effect of Innate on the Inflammatory Response to Endotoxin
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 100 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT01143480Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Novant Health Heart and Vascular Institute, Charlotte
- Velocity Clinical Research - Durham, Durham
- Moses H Cone Memorial Hospital, Greensboro
- dan 7 lagi
Mengambil pesertaFasa 3
Umur 45 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07037433A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- NC Heart and Vascular Research, LLC, Raleigh
- Javara Inc. - Wake Forest University Health Sciences, Winston-Salem
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07521007Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Metrolina Nephrology Associates, PA, Charlotte
- Durham Nephrology Associates, PA, Durham
- Duke Translational Medicine Institute, Durham
- dan 3 lagi
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Asheville
- Research Site, Chapel Hill
- Research Site, Charlotte
- dan 11 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT07000357Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Wake Forest University Baptist Medical Center, Winston-Salem
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06813911Pelacarsen Roll-over Extension Program
- Monroe Biomedical Research, Monroe
- Alliance Medical Ministry, Raleigh
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06875973Pharmacogenomic Informed Statin Prescribing
- Durham VA Medical Center, Durham, NC, Durham
Mengambil peserta
Umur 40 hingga 75 · Semua jantina · Dikemas kini 13 Apr 2026 · NCT06568601Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
- Wake Forest University Health Sciences, Winston-Salem
Mengambil pesertaFasa 2
Umur 40 hingga 75 · Semua jantina · Dikemas kini 27 Feb 2026 · NCT06488105Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Durham VA Medical Center, Durham, NC, Durham
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Dis 2025 · NCT02915198Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.